VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,093,000 | -41.1% | 194,100 | -48.3% | 0.32% | -16.0% |
| Q3 2018 | $6,952,000 | +17.2% | 375,355 | +41.2% | 0.38% | -17.8% |
| Q2 2018 | $5,930,000 | +19.4% | 265,800 | +17.7% | 0.46% | -0.9% |
| Q1 2018 | $4,966,000 | +71.1% | 225,900 | +80.9% | 0.47% | +21.8% |
| Q4 2017 | $2,902,000 | -23.0% | 124,891 | -23.9% | 0.38% | -43.5% |
| Q3 2017 | $3,768,000 | -8.8% | 164,100 | -12.3% | 0.68% | +11.8% |
| Q2 2017 | $4,132,000 | +253.8% | 187,095 | +265.3% | 0.61% | +62.8% |
| Q1 2017 | $1,168,000 | +4.1% | 51,219 | -4.5% | 0.37% | -3.9% |
| Q4 2016 | $1,122,000 | -64.3% | 53,619 | -54.9% | 0.39% | +8.1% |
| Q3 2016 | $3,141,000 | -74.3% | 118,854 | -73.1% | 0.36% | -33.6% |
| Q2 2016 | $12,242,000 | – | 441,790 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |